Trial NCT02412371

View at ClinicalTrials.gov 
Org. Study IDs: M14-360
Secondary IDs: 2016-001659-32

Last trial update was posted on 2020-07-22

MeSH Interventions

Carboplatin Paclitaxel Veliparib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer Stage III

Stopping Reasons

Phase 2 was not conducted due to a change in the standard of care for newly diagnosed, unresectable Stage III NSCLC

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID